Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Biochemical Pharmacology|December 1, 2001
Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanismM S Poruchynsky, P Giannakakou, Y Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2011
Key role for IL-21 in experimental autoimmune uveitisLu Wang, Cheng-Rong Yu, Hyoung-Pyo Kim, et al.
The Journal of Investigative Dermatology|October 21, 2011
Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinomaGirish K Patel, Carole L Yee, Atsushi Terunuma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
CCR6 colocalizes with CD18 and enhances adhesion to activated endothelial cells in CCR6-transduced Jurkat T cellsWusi Maki, Romeo E Morales, Virginia A Carroll, et al.
Breast Cancer Research and Treatment|March 4, 2003
Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell linesChad A Ellis, Michele D Vos, Meredith Wickline, et al.
Journal of Immunology Research|June 26, 2019
The Role of O-Antigen in LPS-Induced Activation of Human NK CellsLeonid M Kanevskiy, Sofya A Erokhina, Maria A Streltsova, et al.
Blood|June 22, 2006
Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic micePhilip J Lucas, Seong-Jin Kim, Crystal L Mackall, et al.
Blood|May 24, 2003
Proliferation kinetics of subpopulations of human marrow cells determined by quantifying in vivo incorporation of [2H2]-glucose into DNA of S-phase cellsGretchen N Schwartz, Barbara A Vance, Benjamin M Levine, et al.
Journal of Leukocyte Biology|September 15, 2020
CD56dim CD57- NKG2C+ NK cells retaining proliferative potential are possible precursors of CD57+ NKG2C+ memory-like NK cellsPolina A Kobyzeva, Maria A Streltsova, Sofya A Erokhina, et al.
Plos One|December 6, 2018
Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2AMaria A Streltsova, Sofya A Erokhina, Leonid M Kanevskiy, et al.
Pageof 11